Bayer sues Teva for patent infringement
German drugmaker Bayer has filed a lawsuit against generic competitor Teva Pharmaceuticals of Israel in the US Federal Court for infringing its patent that prevents a generic version of erectile dysfunction drug Levitra from being sold in the US.
German drugmaker Bayer has filed a lawsuit against generic competitor Teva Pharmaceuticals of Israel in the US Federal Court for infringing its patent that prevents a generic version of erectile dysfunction drug Levitra from being sold in the US.
"The lawsuit concerns Teva's application to the FDA for approval to market a generic form of Levitra, prior to patent expiration," said Bayer.
The patent at issue in the suit is Bayer Schering Pharma's US Patent No. 6,362,178, expiring in 2018.
Schering-Plough and GlaxoSmithKline market Levitra in the US.